☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Caris Life Sciences
Caris Life Sciences Collaborates with Merck KGaA to Discover and Develop Antibody Drug Conjugate for Cancer Treatment
April 4, 2024
Caris Life Sciences Entered into a Multi-Year Strategic Option and License Agreement with Xencor for Novel XmAb Bispecific Antibod...
August 2, 2022
PharmaShots Interview: In Conversation with Caris Life Sciences’, CBO, Brian Lamon, Where he Shares Insights on Opening of New Liq...
July 4, 2022
PharmaShots Interview: Caris Life Sciences' Dr. Spetzler Shares Insight on AI-Based MI FOLFOXai Predictor
July 27, 2021
PharmaShots Interview: Caris Life Sciences' Dr. Spetzler Shares Insight on AI-Powered Clinico-Genomic Data Platform
December 1, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.